Series C Pharmaceutical Companies

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

Aizon is a cloud-based SaaS platform that helps optimize industrial processes in biotech and pharma.

Prism is a biotechnology company that develops therapeutic drugs that cure intractable diseases using unique peptide mimic technology.

Accent Therapeutics is a biopharmaceutical company.

SmithRx is reinventing PBMs with modern technology, client alignment, and 100% transparency.

Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

Kanaph Therapeutics is a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules.

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.

MitrAssist offers a minimally invasive approach to mitral regurgitation treatment.

Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

Antheia uses synthetic biology to produce biosynthetic KSMs and APIs for essential medicines through engineered microbial fermentation.

Veritas In Silico is a research and sales of pharmaceuticals firm that offers drug discovery platform technology with scientific evidences.

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

Certis Oncology Solutions is a precision oncology and translational science company serving patients, oncologists and drug developers

Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

Synthace is a SaaS Life Sciences R&D Digital Experiment Platform.

Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists